Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment
- PMID: 15206742
- DOI: 10.1007/978-1-4615-0135-0_32
Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment
Abstract
The kynurenine pathway from tryptophan generates compounds which can act on glutamate receptors in peripheral tissues or modulate free radical activity. We have measured the concentrations of several of these compounds in the plasma of patients with rheumatoid arthritis (RA) and osteoporosis (OP) before treatment with drugs and then at monthly intervals for 6 months during treatment. Kynurenine analysis was performed by HPLC. Compared with healthy controls, RA patients showed significantly decreased baseline levels of tryptophan, 3-hydroxykynurenine and 3-hydroxyanthranilic acid and increased levels of kynurenine and xanthurenic acid, while kynurenic acid concentrations were normal. Different results were recorded from patients with OP with only a significant reduction in tryptophan and 3-hydroxyanthranilic acid when compared with healthy controls. During 6 months of treating the RA patients with prednisolone or methotrexate, and the OP patients with raloxifene or etidronate and calcium there were significant therapeutic responses and a significant trend towards a reduction in levels of neopterin in RA patients receiving methotrexate but no changes in the profiles of tryptophan metabolites. The results are consistent with the induction of indoleamine-2,3-dioxygenase (IDO) in both RA and OP but with far greater activation of the pathway in the much more inflammatory condition, i.e. RA. It is concluded that there are changes in the kynurenine pathway, which may modify the activation of tissue glutamate receptors, in RA and OP, but that these are not affected by the drug treatments studied.
Similar articles
-
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1078-87. doi: 10.1111/j.1440-1681.2006.04490.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17042918
-
Neopterin Levels and Indoleamine 2,3-Dioxygenase Activity as Biomarkers of Immune System Activation and Childhood Allergic Diseases.Ann Lab Med. 2019 May;39(3):284-290. doi: 10.3343/alm.2019.39.3.284. Ann Lab Med. 2019. PMID: 30623620 Free PMC article.
-
Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.J Rheumatol. 2003 Sep;30(9):1935-9. J Rheumatol. 2003. PMID: 12966593
-
Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?Biomolecules. 2020 Sep 4;10(9):1280. doi: 10.3390/biom10091280. Biomolecules. 2020. PMID: 32899743 Free PMC article. Review.
-
Neopterin as a biomarker of immune response in cancer patients.Ann Transl Med. 2017 Jul;5(13):280. doi: 10.21037/atm.2017.06.29. Ann Transl Med. 2017. PMID: 28758106 Free PMC article. Review.
Cited by
-
Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis.Curr Rheumatol Rep. 2024 Apr;26(4):124-132. doi: 10.1007/s11926-024-01135-y. Epub 2024 Feb 1. Curr Rheumatol Rep. 2024. PMID: 38300467 Review.
-
Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study.J Endocr Soc. 2023 Nov 30;8(1):bvad149. doi: 10.1210/jendso/bvad149. eCollection 2023 Dec 1. J Endocr Soc. 2023. PMID: 38116129 Free PMC article.
-
Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice.J Clin Invest. 2023 Dec 19;134(4):e167671. doi: 10.1172/JCI167671. J Clin Invest. 2023. PMID: 38113112 Free PMC article.
-
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.Ann Rheum Dis. 2024 Feb 15;83(3):312-323. doi: 10.1136/ard-2023-224014. Ann Rheum Dis. 2024. PMID: 38049981 Free PMC article.
-
The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases.Front Immunol. 2023 Oct 23;14:1284133. doi: 10.3389/fimmu.2023.1284133. eCollection 2023. Front Immunol. 2023. PMID: 37936710 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous